Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Methods for infectious disease modelling using genomics

This EMBO Practical Course offers a comprehensive introduction to the principles, tools, and techniques of infectious disease modelling, with a special focus on integrating genomic [...]

Go to Top